215 related articles for article (PubMed ID: 34712325)
21. Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma.
Zhang S; Xiao X; Wang Y; Song T; Li C; Bao H; Liu Q; Sun G; Sun X; Su T; Fu T; Wang Y; Liang P
Front Genet; 2022; 13():899125. PubMed ID: 35719378
[No Abstract] [Full Text] [Related]
22. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
23. Identification of a Novel Gene Signature Based on Kinesin Family Members to Predict Prognosis in Glioma.
Pan D; Fang X; Li J
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837615
[No Abstract] [Full Text] [Related]
24. An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma.
Wang S; Xu X
Front Oncol; 2021; 11():564960. PubMed ID: 33859933
[No Abstract] [Full Text] [Related]
25. New Autophagy-Ferroptosis Gene Signature Predicts Survival in Glioma.
Zhou L; Jiang Z; Shi Z; Zhao W; Lu Z; Xie Y; Zhang B; Lu H; Tan G; Wang Z
Front Cell Dev Biol; 2021; 9():739097. PubMed ID: 34869322
[No Abstract] [Full Text] [Related]
26. A Focal Adhesion-Related Gene Signature Predicts Prognosis in Glioma and Correlates With Radiation Response and Immune Microenvironment.
Li H; Wang G; Wang W; Pan J; Zhou H; Han X; Su L; Ma Z; Hou L; Xue X
Front Oncol; 2021; 11():698278. PubMed ID: 34631528
[TBL] [Abstract][Full Text] [Related]
27. Construction of a novel microRNA-based signature for predicting the prognosis of glioma.
Liu G; Rong X; Lin X; Wang H; He L; Peng Y
Int J Neurosci; 2023 Dec; 133(8):840-850. PubMed ID: 35353669
[No Abstract] [Full Text] [Related]
28. Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma.
Zhao J; Liu Z; Zheng X; Gao H; Li L
Front Genet; 2021; 12():753680. PubMed ID: 34819946
[No Abstract] [Full Text] [Related]
29. A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma.
Xia P; Huang Y; Chen G
Front Oncol; 2022; 12():940220. PubMed ID: 36033510
[TBL] [Abstract][Full Text] [Related]
30. Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma.
Ji B; Chen L; Cai Q; Guo Q; Chen Z; He D
PeerJ; 2020; 8():e9943. PubMed ID: 33062427
[TBL] [Abstract][Full Text] [Related]
31. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
32. Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma.
Wang M; Zhou Z; Zheng J; Xiao W; Zhu J; Zhang C; Jiang X
Front Oncol; 2021; 11():650153. PubMed ID: 34055619
[TBL] [Abstract][Full Text] [Related]
33. Identification of a tripartite motif family gene signature for predicting the prognosis of patients with glioma.
Xiao S; Yu J; Yuan X; Chen Q
Am J Transl Res; 2022; 14(3):1535-1550. PubMed ID: 35422900
[TBL] [Abstract][Full Text] [Related]
34. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of a TNF family based-signature in diffuse gliomas with regard to prognosis and immune significance.
Wang QW; Lin WW; Zhu YJ
Cell Commun Signal; 2022 Jan; 20(1):6. PubMed ID: 35000592
[TBL] [Abstract][Full Text] [Related]
36. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H
Front Oncol; 2020; 10():590352. PubMed ID: 33392085
[TBL] [Abstract][Full Text] [Related]
37. Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma.
Li L; Yang Z; Zheng Y; Chen Z; Yue X; Bian E; Zhao B
BMC Neurol; 2022 May; 22(1):192. PubMed ID: 35614390
[TBL] [Abstract][Full Text] [Related]
38. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
Front Oncol; 2020; 10():1119. PubMed ID: 32974125
[No Abstract] [Full Text] [Related]
39. A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
Tu Z; Shu L; Li J; Wu L; Tao C; Ye M; Zhu X; Huang K
Front Cell Dev Biol; 2020; 8():588368. PubMed ID: 33634092
[TBL] [Abstract][Full Text] [Related]
40. A robust two-gene signature for glioblastoma survival prediction.
Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]